ArdorComm Media Group

Contact Us
logo
Menu
logo
ArdorComm ArdorComm ArdorComm

Healthcare Innovation

MediBuddy Launches BuddyCare to Revolutionize Cashless Healthcare

Leave a Comment / By / Health & Wellness Community

MediBuddy has unveiled BuddyCare, a networking platform under the India Health Care Collaborators (IHCC) initiative, to strengthen India’s cashless primary healthcare infrastructure. This innovative platform connects insurance companies, healthcare providers, and intermediaries, fostering a robust ecosystem in alignment with India’s ‘Insurance for All by 2047’ vision. BuddyCare offers comprehensive services for insurers, including pre-policy issuance, real-time risk quantification, and seamless post-policy health and wellness service delivery. By integrating advanced fraud-resilient systems like the ‘Sherlock’ Fraud Detection System, BuddyCare enhances transparency and efficiency in outpatient department (OPD) processes. Satish Kannan, Co-founder and CEO of MediBuddy, emphasized the platform’s significance, stating, “IHCC marks a transformative step in redefining healthcare delivery in India. By integrating innovation, collaboration, and quality, we aim to create a universally accessible, cashless, and insurance-integrated healthcare model.” With a network of over 100,000 doctors, IHCC bridges gaps between life, health, and wellness insurance. Leveraging AI-driven tools, the platform improves risk management and service delivery while offering medical consultations, diagnostics, medicine delivery, and concierge support. MediBuddy also extends its reach to Non-Resident Indians (NRIs), ensuring inclusive healthcare solutions. As part of its Corporate Social Responsibility (CSR) initiatives, the company runs paramedical training programs to bolster healthcare infrastructure nationwide. This initiative not only supports MediBuddy’s mission but also aligns with national policy objectives. By integrating technology and strategic partnerships, BuddyCare is set to redefine healthcare delivery across urban and rural India, ensuring greater accessibility, affordability, and efficiency. Source: expresshealthcare Photo Credit: expresshealthcare

Singapore’s Ministry of Health Commits SG$200 Million to AI-Driven Healthcare Innovations

Leave a Comment / By / Health & Wellness Community
Health news

The Singaporean Ministry of Health (MOH) has announced a significant investment of SG$200 million (approximately $150 million) over the next five years to enhance the implementation of AI technologies across the country’s healthcare system. This financial boost is part of the MOH Health Innovation Fund, aimed at advancing technological innovations and expanding AI integration into system-wide, national projects. Key Initiatives Supported by the Investment: Generative AI for Record Automation: A major focus of the funding will be a generative AI project designed to automate the updating of medical records. The MOH plans to roll out this project across the public healthcare system by the end of 2025, with the goal of streamlining administrative tasks such as documentation and the summarisation of medical records. AI in Medical Imaging: The MOH will also invest in medical imaging AI for early detection of breast cancer. This technology, currently undergoing validation, is expected to be adopted as part of a national subsidised screening programme by the end of 2025. The initiative will enhance early detection and diagnosis through advanced AI-assisted imaging tools. Broader Trends in Singapore’s AI-Driven Healthcare: Singapore’s healthcare system has been making strides in integrating AI and generative AI (genAI) technologies, backed by the government. The national health tech agency Synapxe has expanded its partnership with Microsoft, working on projects like Secure GPT for Healthcare Professionals, which develops large language models (LLMs) for healthcare applications. The National University Health System (NUHS) has also developed RUSSELL-GPT, an AI chatbot that summarises patient case notes and generates referral letters. Additionally, Singapore General Hospital is exploring genAI use in pre-surgery assessments, and hospitals under SingHealth have adopted chest X-ray analysis AI through AimSG, a national radiology AI platform. The platform, launched last year, allows hospitals to integrate validated AI tools into their workflows. Genetic Testing Programme: The MOH also announced plans to launch a national genetic testing programme by mid-2025, with a focus on Familial Hypercholesterolemia, a genetic condition affecting cholesterol levels. This marks another step towards incorporating advanced technology into personalised healthcare. Strengthening AI Governance: As AI becomes more central to Singapore’s healthcare system, the MOH is committed to improving national governance for AI use in healthcare. The ministry emphasized the need to balance innovation with safety, ensuring that new AI solutions are implemented securely and deliver safe care to patients. Conclusion: Singapore’s investment in AI-driven healthcare innovations demonstrates its forward-thinking approach to enhancing healthcare delivery. With a focus on automation, early detection, and improving overall patient care Source: Business Standard

India Became ‘Pharmacy of the World’ During Covid-19: JP Nadda

Leave a Comment / By / Health & Wellness Community
ArdorComm news

Union Minister of Health and Family Welfare, JP Nadda, hailed India as the ‘Pharmacy of the World’ on Monday while emphasizing the country’s significant contributions to global healthcare during the Covid-19 pandemic. Nadda was speaking at the 19th International Conference of Drug Regulatory Authorities (ICDRA) in New Delhi, where leaders from over 120 countries gathered to discuss regulatory practices and collaborative solutions to enhance global healthcare standards. “This prestigious platform [19th ICDRA] reflects our shared commitment to enhancing global healthcare standards and safeguarding public health,” Nadda said. He highlighted India’s pivotal role in addressing global health challenges through innovation, resilience, and collaboration. India’s Covid-19 Response: Vaccine Production and Global Impact Nadda elaborated on India’s rapid response during the pandemic, particularly its ability to ramp up vaccine production to meet both domestic and international needs. “During the unprecedented Covid-19 pandemic, India emerged not only as a global leader in health resilience and innovation but also reaffirmed its role as the pharmacy of the world,” he said. India’s extensive vaccination campaign, which successfully inoculated over a billion people, was described as a major milestone. Nadda credited healthcare workers and government initiatives for ensuring affordable access to essential medicines, vaccines, and medical supplies for nations around the globe. He also underscored India’s assistance to over 150 countries during the pandemic, driven by the ethos of “Vasudhaiva Kutumbakam,” the ancient Indian philosophy that emphasizes “the world is one family.” Cross-Border Collaboration and Regulatory Advancements Nadda emphasized that cross-border collaboration is essential for addressing global healthcare challenges. “The theme of this conference resonates deeply with our core belief that collaboration across borders, sectors, and disciplines is essential for creating lasting health solutions,” he stated. He also outlined India’s efforts to modernize its regulatory framework, highlighting the establishment of eight operational drug testing laboratories, with two more in the pipeline. Furthermore, eight mini testing labs have been set up at various ports to expedite the testing of imported materials. Over 95 percent of regulatory processes in India have been digitized, and the country’s medical device industry is now under regulation. With India’s healthcare system playing a crucial role in ensuring affordable access to medical supplies and vaccines during the pandemic, Nadda emphasized the importance of continued innovation and global cooperation to build a healthier, more resilient world. Source: Business Standard

Tamil Nadu Health Department Wins UN Award for ‘Makkalai Thedi Maruthuvam’ Scheme

Leave a Comment / By / Health & Wellness Community
ArdorComm news

Tamil Nadu’s Health and Family Welfare Department has been awarded the prestigious ‘UN Interagency Task Force Awards (UNIATF) for 2024’ for its flagship healthcare initiative, Makkalai Thedi Maruthuvam. The award, announced under the category of Ministries of Health, recognizes the state’s exemplary efforts in addressing Non-Communicable Diseases (NCDs) through innovation and technology. Health Minister Ma. Subramanian, in a press release on Monday, celebrated the recognition, emphasizing that the scheme has significantly improved access to healthcare for vulnerable populations by delivering comprehensive home-based services. The programme strengthens the health system for NCDs at all levels, providing treatment and follow-up care directly to beneficiaries’ doorsteps. Chief Minister M.K. Stalin lauded the success of Makkalai Thedi Maruthuvam, which has benefitted over 1.80 crore people, in a post on X (formerly Twitter). He praised the initiative for transforming lives and delivering essential healthcare to the masses. The Chief Minister also congratulated the Health Department, including its doctors, nurses, and staff, for their relentless efforts in making the scheme a success. Minister Subramanian hailed the award as a validation of the department’s work and a motivation to continue addressing NCD challenges. He noted that the recognition would inspire further efforts toward improving control rates and managing complications related to NCDs. The UNIATF awards are granted annually to acknowledge outstanding contributions in NCD and mental health management. Tamil Nadu’s Health Department was one of 14 global organizations honored at the 79th UN General Assembly in New York on September 25. Source: The Hindu

Healthcare Innovation Set to Double, Reaching $60 Billion Opportunity in India by FY28

Leave a Comment / By / Health & Wellness Community

A recent report by Bain & Company and HealthQuad reveals a promising outlook for healthcare innovation in India, projecting its value to double to $60 billion by FY28. This growth surge is part of India’s broader healthcare market, expected to reach $320 billion by the same time, driven by a compound annual growth rate (CAGR) of 12%. Healthcare innovation currently constitutes 15% ($30 billion) of India’s healthcare market, with approximately 55% of it export-oriented. Aarthi Rao from Bain & Company anticipates substantial expansion, emphasizing not only value engineering but also business innovation, particularly in biotech, vaccines, and med-tech sectors. The report identifies four key segments driving healthcare innovation: pharma services, health-tech, vaccines, and biotech, and med-tech. Health-tech, which includes consumer-facing solutions like telemedicine and enterprise-facing solutions like B2B e-commerce, witnessed a significant boost, doubling from $3 billion in FY20 to $7 billion in FY23. India’s success in the vaccines and biotech market has been remarkable, with revenues reaching $4 billion in FY23, driven by exports. The country has become a vaccine powerhouse, supplying around 60% of global vaccine demand. Additionally, biotech startups are leveraging new technologies to develop innovative products. Pharma services remain a dominant force, constituting around 50% of the healthcare innovation market. India’s pharma services market, valued at $16 billion in FY23, has seen significant growth driven by exports and the country’s emergence as a leading CDMO player globally. Charles-Antoine Jannsen from HealthQuad notes India’s evolution in the biologics space, emphasizing its newfound strengths in research, manufacturing, and export. The accelerated adoption of telemedicine and e-pharmacies during the pandemic has further propelled health-tech growth. Overall, India’s healthcare innovation landscape presents a compelling growth story, driven by technological advancements, favorable government initiatives, and an expanding global footprint.  

AIIMS Bhubaneswar Successfully Tests Drones for Healthcare Delivery in Odisha

Leave a Comment / By / Health & Wellness Community

AIIMS Bhubaneswar achieved a significant milestone on January 23 by successfully conducting an experimental trial utilizing drones to enhance healthcare services in Odisha. The unmanned aerial vehicle covered a remarkable distance of 120 km from AIIMS Bhubaneswar to the Community Health Centre in Tangi in just 1.10 hours, marking a groundbreaking advancement in medical logistics. The drones were specifically designed to transport essential blood supplies, weighing approximately 2 kg, with the entire journey executed seamlessly, showcasing the potential for integrating drone technology into the healthcare system. AIIMS Bhubaneswar Director, Ashutosh Biswas, expressed his satisfaction with the trial, emphasizing the commitment of the national institute to develop a model that seamlessly integrates technology to supplement existing logistics methods. Director Biswas highlighted the significance of this technology in bolstering healthcare services in remote, tribal, and semi-urban areas. Drones have the capacity to transport a variety of medical supplies, including vaccines, essential drugs, and diagnostic samples. This successful trial by AIIMS Bhubaneswar, a leading tertiary healthcare provider, opens new possibilities for enhancing healthcare accessibility for the people of Odisha. In an exclusive statement to ANI, Director Biswas stated, “Induction of drone delivery can boost the healthcare services in rural, tribal, and semi-urban locations. These drones can carry multiple health products, including vaccines, essential drugs, and diagnostic samples. AIIMS Bhubaneswar, as a leading tertiary healthcare provider, has created this opportunity for the people of Odisha.” The successful integration of drones in healthcare delivery marks a transformative step towards more efficient and timely medical services in challenging terrains and remote regions.